Circulation ResearchMolecular BiologyPeer-reviewed journal article
Obesity Increases Atherosclerosis Susceptibility via Inter-tissue miR-30e-SLC7A11 Axis
Chen WangiD, Jianqing SheiD, Xiaoli Qian, Haoyu WuiD, Wenyang Hao, Xiao Liang, Ning GuoiD, Xulei Dai, Fangzhou HeiD, Sisi HeiD, Jin Zhang, Yuyang Lei, Xiaozhen ZhuoiD, Hongbing LiiD, Yongbai LuoiD, Kai DengiD, Yi LiuiD, Shanshan Gao, Yuan XiaoiD, Hui LiuiD, Ting Bai, Ying XiongiD, John Y.-J. ShyyiD, Zuyi YuaniD
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
Abstract
BackgroundWith obesity as a risk factor for atherosclerotic disease, recent research suggests that adipose tissue in obese animal models and humans can generate endocrine-like molecules that affect arterial health later on. Previous studies showed that microRNA-30e (miR-30e) level is elevated in atherosclerosis and solute carrier family 7 member 11 (SLC7A11), a cystine/glutamate transporter, is involved in atherogenesis. However, whether an endocrine-like link between the adipose-derived miR-30e-5p and SLC7A11 in the vascular endothelium can lead to obesity-caused atherosclerosis is unknown. MethodsMiRNA data mining and RT-PCR validations were used to demonstrate the positive association among serum level of miR-30e-5p, obesity, and coronary arterial disease in human patients. Transcriptomics (RNA-seq and single-nucleus RNA-seq), metabolomics, and in silico analysis were used to establish a miR-30e-5p-SLC7A11 regulation of central carbon metabolism, mitochondrial and endothelial cell (EC) function. Mouse models with EC-specific Slc7a11 knockout (EC-Slc7a11-/-) and gain or loss of function of miR-30e-5p were used to elucidate the detrimental role of this endocrine-like axis in obesity-related atherosclerosis. ResultsThe level of adipocyte-derived miR-30e-5p was significantly upregulated in obese humans with coronary artery disease and obese and atherosclerotic mice. Via serum exosomes, the adipocyte-generated miR-30e-5p targeted SLC7A11 mRNA in vascular ECs. SLC7A11 deficiency due to miR-30e-5p targeting dysregulated glutamate/cystine metabolism increased glycolysis, reduced oxidative phosphorylation, and impaired mitochondrial function. The EC dysfunction could be rectified by SLC7A11 overexpression or miR-30e-5p antagonism. Exogenously delivered miR-30e-5p phenocopied the increased atherosclerosis in EC-Slc7a11-/- mice. In contrast, miR-30e-5p antagomir treatment reduced atherosclerosis in Apoe-/- and ob/ob mice. ConclusionOur multi-omics approaches demonstrates that the adipose-derived miR-30e-5p downregulated SLC7A11 mRNA in ECs via tissue crosstalk. The resulting EC dysfunction led to obesity-related atherosclerosis in mice. These findings underscore a causality between obesity and atherosclerosis in the context of cardiovascular-kidney-metabolic syndrome.
- organism: mouse
- organism: human
- assay: bulk RNA-seq
- assay: metabolomics
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites through Endothelial Fatty Acid Uptake
D. Pirri, S. Tian, … P. C. Evans·bioRxiv·Dec 5, 2023
- Loss of endothelial cell heterogeneity in arteries after obesogenic diet
Luke S. Dunaway, Melissa A. Luse, … Brant E. Isakson·bioRxiv·Jun 23, 2023
- Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake
Lu Sun, Rui‐Xue Leng, … Jianping Weng·Journal of Clinical InvestigationPeer-reviewed·Apr 1, 2025
- SCUBE-1 in The Diagnosis and Follow-Up Of Subclinical Atherosclerosis in The Experimental Diabetes Mellitus and Obesity Model
M. Kök, H. Y. Elidag, … D. Dora·bioRxiv·Oct 3, 2023
- The Secretome of Liver X Receptor Agonist Treated Early Outgrowth Cells Decreases Atherosclerosis in Ldlr-/- Mice
A. Rasheed, S. Shawky, … C. L. Cummins·bioRxiv·Sep 4, 2019
- MicroRNA-541-3p alters lipoproteins to reduce atherosclerosis by degrading Znf101 and Casz1 transcription factors
A. Ansari, P. K. Yadav, … M. M. Hussain·bioRxiv·Nov 1, 2023